Yuval Cohen
Vorstandsvorsitzender bei CORBUS PHARMACEUTICALS HOLDINGS, INC.
Vermögen: 447 388 $ am 31.05.2024
Aktive Positionen von Yuval Cohen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 11.04.2014 | - |
| Vorstandsvorsitzender | 11.04.2014 | - | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Direktor/Vorstandsmitglied | 01.07.2013 | - |
| Vorstandsvorsitzender | 01.07.2013 | - |
Karriereverlauf von Yuval Cohen
Ehemalige bekannte Positionen von Yuval Cohen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2005 | 01.02.2013 |
| Gründer | 01.01.2005 | 01.12.2013 | |
| Corporate Officer/Principal | 01.02.2013 | 01.12.2013 | |
| Präsident | 01.01.2005 | 01.02.2013 |
Ausbildung von Yuval Cohen
| University of Cape Town | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
| Südafrika | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
- Börse
- Insiders
- Yuval Cohen
- Erfahrung
